XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Statements of changes in shareholders' equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Ordinary shares
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive income (loss)
Retained earnings (accumulated deficit)
Retained earnings (accumulated deficit)
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020     102,334,276          
Beginning balance at Dec. 31, 2020 $ 476,526     $ 1,111,435   $ (3,832) $ (631,077)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 94,900     94,900        
Exercise of options (in shares)     1,585,617          
Exercise of options 21,182     21,182        
Issuance of shares in connection with employee stock purchase plan (in shares)     51,370          
Issuance of shares in connection with employee stock purchase plan 4,546     4,546        
Other comprehensive income (loss), net of tax expense 663         663    
Net income (loss) (58,351)           (58,351)  
Ending balance (in shares) at Dec. 31, 2021     103,971,263          
Ending balance at Dec. 31, 2021 410,494 $ (128,972)   1,099,589 $ (132,474) (3,169) (685,926) $ 3,502
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation 106,955     106,955        
Exercise of options (in shares)     991,884          
Exercise of options 10,295     10,295        
Issuance of shares in connection with employee stock purchase plan (in shares)     86,264          
Issuance of shares in connection with employee stock purchase plan 5,224     5,224        
Other comprehensive income (loss), net of tax expense 736         736    
Net income (loss) (92,534)           (92,534)  
Ending balance (in shares) at Dec. 31, 2022     105,049,411          
Ending balance at Dec. 31, 2022 441,170     1,222,063   (2,433) (778,460)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Share-based compensation $ 115,608     115,608        
Exercise of options (in shares) 827,078   1,823,851          
Exercise of options $ 11,381     11,381        
Issuance of shares in connection with employee stock purchase plan (in shares)     202,492          
Issuance of shares in connection with employee stock purchase plan 4,416     4,416        
Other comprehensive income (loss), net of tax expense (3,036)         (3,036)    
Net income (loss) (207,043)           (207,043)  
Ending balance (in shares) at Dec. 31, 2023     107,075,754          
Ending balance at Dec. 31, 2023 $ 362,496     $ 1,353,468   $ (5,469) $ (985,503)